HETEROCYCLIC COMPOUND

The present invention provides a prophylactic or therapeutic agent for autoimmune disease (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus) and the like, the agent having excellent Tyk...

Full description

Saved in:
Bibliographic Details
Main Authors YOGO, TAKATOSHI, SAITOH, MORIHISA, YUKAWA, TAKAFUMI, TOKUNAGA, NORIHITO, KAMEI, TAKU, OHBA, YUSUKE
Format Patent
LanguageEnglish
French
Japanese
Published 05.02.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a prophylactic or therapeutic agent for autoimmune disease (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus) and the like, the agent having excellent Tyk2 inhibitory effect. The present invention pertains to a compound or salt thereof represented by formula (I) (in the formula, the reference signs are as defined in the present specification). La présente invention concerne un agent prophylactique ou thérapeutique pour une maladie auto-immune (par exemple, le psoriasis, la polyarthrite rhumatoïde, la maladie intestinale inflammatoire, le syndrome de Sjögren, la maladie de Behçet, la sclérose en plaques, le lupus érythémateux systémique) et analogue, l'agent ayant un excellent effet inhibiteur de Tyk2. La présente invention se rapporte également à un composé ou un sel de celui-ci représenté par la formule (I) (dans la formule, les signes de référence sont tels que définis dans la description).
Bibliography:Application Number: WO2014JP69907